Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Invested Capital (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Invested Capital for 6 consecutive years, with $142.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital rose 8.22% year-over-year to $142.6 million, compared with a TTM value of $142.6 million through Dec 2025, up 8.22%, and an annual FY2025 reading of $142.6 million, up 8.22% over the prior year.
  • Invested Capital was $142.6 million for Q4 2025 at Viemed Healthcare, up from $135.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $142.6 million in Q4 2025 and bottomed at $90.6 million in Q1 2021.
  • Average Invested Capital over 5 years is $112.7 million, with a median of $106.8 million recorded in 2023.
  • The sharpest move saw Invested Capital soared 56.89% in 2021, then fell 3.49% in 2022.
  • Year by year, Invested Capital stood at $100.6 million in 2021, then dropped by 3.49% to $97.1 million in 2022, then rose by 18.41% to $115.0 million in 2023, then grew by 14.64% to $131.8 million in 2024, then grew by 8.22% to $142.6 million in 2025.
  • Business Quant data shows Invested Capital for VMD at $142.6 million in Q4 2025, $135.2 million in Q3 2025, and $142.4 million in Q2 2025.